Form 4: OPKO Health CEO Frost Boosts Stake with $650K Stock Purchase

OPKO Health's CEO and Chairman, Phillip Frost, M.D., increased his beneficial ownership by purchasing over 530,000 shares of common stock through various trusts.

Summary

• Phillip Frost, M.D., CEO and Chairman of OPKO Health, Inc., reported multiple purchases of common stock.
• The transactions occurred on November 18, 2025.
• A total of 530,290 shares of common stock were acquired through various purchases.
• The purchase prices for these shares ranged from $1.245 to $1.29 per share.
• Following these transactions, the total beneficial ownership attributed to Phillip Frost, M.D., is 248,662,576 shares, comprising 214,966,448 shares held indirectly by Frost Gamma Investments Trust, 3,568,951 shares held directly, and 30,127,177 shares held indirectly by Frost Nevada Investments Trust.

Sentiment

Score: 8

Explanation: The significant insider buying by the CEO and Chairman, Phillip Frost, M.D., suggests strong confidence in the company's future prospects and current valuation, which is a positive signal for investors.

Positives

• Significant insider buying by the CEO and Chairman, Phillip Frost, M.D., indicates strong confidence in the company's future prospects and current valuation.
• The acquisition of 530,290 shares at prices ranging from $1.245 to $1.29 represents a substantial personal investment by a key executive.
• Increased beneficial ownership by a top executive further aligns management's interests with those of other shareholders.

Future Outlook

NA

Industry Context

Insider buying by a CEO can signal strong internal confidence, potentially differentiating the company from peers facing broader industry headwinds or uncertainties. Such actions are often closely watched by investors as an indicator of management's belief in the company's intrinsic value.

Related Party Transactions

• Phillip Frost, M.D., as CEO, Chairman, and a 10% owner, is a related party to OPKO Health, Inc. The reported transactions involve his indirect acquisition of company common stock through Frost Gamma Investments Trust and his beneficial ownership through Frost Nevada Investments Trust.

Stakeholder Impact

• Shareholders may view the significant insider buying as a positive indicator of management's belief in the company's value, potentially increasing investor confidence.
• The transactions reinforce the alignment of interests between the CEO and other shareholders.

Key Dates

Recommendation

The substantial stock purchases by CEO and Chairman Phillip Frost, M.D., signal strong conviction in OPKO Health's future performance and current valuation. Such significant insider buying often precedes positive developments or reflects a belief that the stock is undervalued, making it a compelling 'buy' signal for investors.

Keywords

OPKO Health, OPK, Phillip Frost, Insider Buying, Form 4, Stock Purchase, CEO, Chairman, Beneficial Ownership, Equity Transaction